Health
HPV Vaccine Generally Well Tolerated in Males – HealthDay
Disproportionate reports found for some adverse events, including syncope, with reporting odds ratio of 2.85
WEDNESDAY, Nov. 4, 2020 (HealthDay News) — Human papillomavirus (HPV) vaccines are safe and well tolerated in males, with few reports of adverse events, according to a study published online Nov. 3 in the British Journal of Clinical Pharmacology.
Giulia Bonaldo, from the University of Bologna in Italy, and colleagues reviewed all reports of adverse events following immunization (AEFI) present in the U.S. Vaccine Adverse Event Reporting System from Jan. 1, 2006, to Sept. 30, 2018, to update knowledge…
-
Noosa News19 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business22 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News21 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General20 hours agoInternal Revenue Service starts cutting 20,000 workers